Actelion (now Janssen Pulmonary Hypertension) logo

Actelion (now Janssen Pulmonary Hypertension) Employee Directory

Pharmaceutical ManufacturingBasel-Stadt, Switzerland201-500 Employees

Actelion, now known as Janssen Pulmonary Hypertension, operates in the pharmaceutical manufacturing industry and is based in Basel, Basel-Stadt, Switzerland. It is part of Janssen, a Johnson & Johnson company, with updates provided on Janssen's LinkedIn channel. The organization employs 201 to 500 people and maintains a web presence at https://janssen.com. The name Janssen Pulmonary Hypertension indicates its integration into Janssen's portfolio related to pulmonary hypertension. Publicly reported recent news shows Janssen Pharmaceuticals, Inc. engaging in external research collaborations with multiple partners, illustrating the kind of activity associated with the Janssen organization.

Find Actelion (now Janssen Pulmonary Hypertension) employees' phone numbers or email addresses

Actelion (now Janssen Pulmonary Hypertension) Global Highlights

Location
Employees

Europe
449

Minus sign iconPlus sign icon
  • Switzerland
    290
  • France
    53
  • United Kingdom Of Great Britain And Northern Ireland
    27
  • Italy
    24
  • Germany
    10
  • Greece
    9
  • Portugal
    5
  • Belgium
    5
  • Spain
    5
  • Sweden
    5
  • Netherlands
    5
  • Poland
    4
  • Austria
    3
  • Hungary
    2
  • Ireland
    1
  • Romania
    1

North America
263

Minus sign iconPlus sign icon
  • United States Of America
    235
  • Mexico
    14
  • Canada
    13
  • Panama
    1

Asia
76

Minus sign iconPlus sign icon
  • Japan
    18
  • Turkey
    17
  • China
    13
  • India
    8
  • Israel
    7
  • Russian Federation
    6
  • Singapore
    4
  • Malaysia
    1
  • Indonesia
    1
  • Philippines
    1

South America
10

Minus sign iconPlus sign icon
  • Brazil
    10

Oceania
6

Minus sign iconPlus sign icon
  • Australia
    6

Africa
3

Minus sign iconPlus sign icon
  • South Africa
    1
  • Tunisia
    1
  • Egypt
    1

Actelion (now Janssen Pulmonary Hypertension)'s Leadership

  • Vice President Head Of Business & Science Affairs at Actelion (now Janssen Pulmonary Hypertension)
    M. H. W.
    Vice President Head Of Business & Science Affairs
  • President at Actelion (now Janssen Pulmonary Hypertension)
    S. T.
    President
  • Head Of Clinical Science Early Projects at Actelion (now Janssen Pulmonary Hypertension)
    S. R.
    Head Of Clinical Science Early Projects
  • Head Of Clinical Development at Actelion (now Janssen Pulmonary Hypertension)
    J. H. P.
    Head Of Clinical Development
  • Head Of Enterprise Risk And Business Continuity Management at Actelion (now Janssen Pulmonary Hypertension)
    J. A.
    Head Of Enterprise Risk And Business Continuity Management
  • Owner at Actelion (now Janssen Pulmonary Hypertension)
    S. A.
    Owner
  • Senior Director, Clinical Science Pediatrics Program Head at Actelion (now Janssen Pulmonary Hypertension)
    C. L.
    Senior Director, Clinical Science Pediatrics Program Head
  • Vice-President, Head Clinical Pharmacology at Actelion (now Janssen Pulmonary Hypertension)
    J. D.
    Vice-President, Head Clinical Pharmacology

Actelion (now Janssen Pulmonary Hypertension) Employee Metrics

100%
50%
0%
2026
2025
  • Customer Success
  • Research
  • Program & Project Management
  • Operations
  • Sales
  • Other
  • Engineering
  • Administrative
  • Biotechnology
  • Healthcare Services
  • Legal

Contact profiles from Actelion (now Janssen Pulmonary Hypertension)

Name
Title
Contact
Location
Last Update
  • President at Actelion (now Janssen Pulmonary Hypertension)
    S. T.
    President
    Japan
    Oct 01, 2026
  • Owner at Actelion (now Janssen Pulmonary Hypertension)
    S. A.
    Owner
    Brazil, Sao Paulo
    Mar 05, 2024
  • Senior Director, Clinical Science Pediatrics Program Head at Actelion (now Janssen Pulmonary Hypertension)
    C. L.
    Senior Director, Clinical Science Pediatrics Program Head
    Switzerland, Basel-City
    Sep 02, 2026
  • Head Of Clinical Science Early Projects at Actelion (now Janssen Pulmonary Hypertension)
    S. R.
    Head Of Clinical Science Early Projects
    Switzerland
    Sep 02, 2026
  • Vice-President, Head Clinical Pharmacology at Actelion (now Janssen Pulmonary Hypertension)
    J. D.
    Vice-President, Head Clinical Pharmacology
    Switzerland
    Mar 07, 2026
  • Head Of Clinical Development at Actelion (now Janssen Pulmonary Hypertension)
    J. H. P.
    Head Of Clinical Development
    South Korea
    Sep 06, 2026
  • Head Of Enterprise Risk And Business Continuity Management at Actelion (now Janssen Pulmonary Hypertension)
    J. A.
    Head Of Enterprise Risk And Business Continuity Management
    Switzerland, Basel-City
    Mar 05, 2024
  • Senior Vice President at Actelion (now Janssen Pulmonary Hypertension)
    J. O.
    Senior Vice President
    Oct 16, 2024
  • Vice President Head Of Business & Science Affairs at Actelion (now Janssen Pulmonary Hypertension)
    M. H. W.
    Vice President Head Of Business & Science Affairs
    Switzerland
    Mar 05, 2024
  • Director, Senior Lab Head & Project Leader at Actelion (now Janssen Pulmonary Hypertension)
    O. C.
    Director, Senior Lab Head & Project Leader
    Switzerland, Basel-City
    Jan 31, 2024

Frequently Asked Questions

What is Actelion (now Janssen Pulmonary Hypertension) known for?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) operates in the Pharmaceutical Manufacturing industry. You can contact Actelion (now Janssen Pulmonary Hypertension)'s main corporate office by phone at . Explore Actelion (now Janssen Pulmonary Hypertension)'s company overview page for more information.

What is Actelion (now Janssen Pulmonary Hypertension)'s most common email format?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) employees' email format typically follows the pattern of First.Last@actelion.com. Trying to find reliable and up-to-date employee contact data? Find more Actelion (now Janssen Pulmonary Hypertension) email formats with LeadIQ.

How many employees does Actelion (now Janssen Pulmonary Hypertension) have currently?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) has approximately 456 employees as of October 2026. These team members are located across 6 continents, including Europe, North America and Asia.

Who are Actelion (now Janssen Pulmonary Hypertension)'s key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Actelion (now Janssen Pulmonary Hypertension)'s key employees include:

  • Vice President Head Of Business & Science Affairs: M. H. W.
  • President: S. T.
  • Head Of Clinical Science Early Projects: S. R.
  • Head Of Clinical Development: J. H. P.
  • Head Of Enterprise Risk And Business Continuity Management: J. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.